Effect of allergen-specific immunotherapy on CD4+ T cells

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 6, 2015, Pages 581-587

  Wambre, Erik ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Allergen immunotherapy; Allergy; Apoptosis; CD4+ T cells; Desensitization; Interleukin 10; Tolerance

Indexed keywords

ALLERGEN; CD4 ANTIGEN; INTERLEUKIN 10;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC DISEASE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DESENSITIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE DEPLETION; METABOLISM; PROCEDURES;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOMODULATION; INTERLEUKIN-10; LYMPHOCYTE DEPLETION; TH2 CELLS;

EID: 84946565124     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000216     Document Type: Review

References (48)

1. Moingeon P. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract 2013;1:228-241.
2. Mobs C, Slotosch C, Loffler H, et al. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. J Immunol 2010;184:2194-2203.
3. Burton BR, Britton GJ, Fang H, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun 2014;5:1-13.
4. Suarez-Fueyo A, Ramos T, Galan A, et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol 2014;133:130-138; e1-2.
5. Maggi E. T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol 2010;161:10-18.
6. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Org J 2015;8:1-12.
7. Wambre E, Van Overtvelt L, Maillere B, et al. Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol 2008;146:99-112.
8. + T cells. J Allergy Clin Immunol 2010;125:1407-1409; e1.
9. Meiler F, Zumkehr J, Klunker S, et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008;205:2887-2898.
10. + cells in the nasal mucosa. J Allergy Clin Immunol 2008;121:1467-1472;72. e1.
11. Rolland JM, Gardner LM, O'Hehir RE. Functional regulatory T cells and allergen immunotherapy. Curr Opin Allergy Clin Immunol 2010;10:559-566.
12. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet (London, England) 2004;363:608-615.
13. Pellerin L, Jenks JA, Begin P, et al. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014;58(2-3):358-368.
14. Abbas AK, Benoist C, Bluestone JA, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013;14:307-308.
15. Mobs C, Ipsen H, Mayer L, et al. Birch pollen immunotherapy results in longterm loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. J Allergy Clin Immunol 2012;130:1108-1116; e6.
16. Bohm L, Maxeiner J, Meyer-Martin H, et al. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma. J Immunol 2015;194:887-897.
17. Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest 2014;124:4678-4680.
18. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5:271-283.
19. Maazi H, Shirinbak S, Willart M, et al. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy. Clin Exp Allergy 2012;42:1519-1528.
20. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-1575.
21. Grindebacke H, Wing K, Andersson AC, et al. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004;34:1364-1372.
22. Syed A, Garcia MA, Lyu SC, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014;133:500-510.
23. Swamy RS, Reshamwala N, Hunter T, et al. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol 2012;130:215-224; e7.
24. Mantel PY, Kuipers H, Boyman O, et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007;5:2847-2861.
25. Hadjur S, Bruno L, Hertweck A, et al. IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1. Immunol Letters 2009;122:37-43.
26. + regulatory T cells. Proc Natl Acad Sci U S A 2007;104:18169-18174.
27. Eisenbarth SC, Zhadkevich A, Ranney P, et al. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88. J Immunol 2004;172:4527-4534.
28. Pillemer BB, Qi Z, Melgert B, et al. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J Immunol 2009;183:155-163.
29. + T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol 2012;129:544-551; 51.e1-7.
30. Wambre E, DeLong JH, James EA, et al. Specific immunotherapy modifies allergen-specific CD4 (+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2014;133:872-879; e7.
31. Pepper M, Linehan JL, Pagan AJ, et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 2010;11:83-89.
32. Ciepiela O, Zawadzka-Krajewska A, Kotula I, et al. Sublingual Immunotherapy for asthma: affects T-cells but does not impact basophil activation. Pediatr Allergy Immunol Pulmonol 2014;27:17-23.
33. Saraiva M, Christensen JR, Veldhoen M, et al. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009;31:209-219.
34. + regulatory T cells suppressing Th2-mediated allergic asthma. Proc Natl Acad Sci U S A 2010;107:8742-8747.
35. Begin P, Nadeau KC. Epigenetic regulation of asthma and allergic disease. Allergy Asthma Clin Immuno 2014;10:1-12.
36. Mondoulet L, Dioszeghy V, Puteaux E, et al. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model. J Allergy Clin Immunol 2015;135:1546-1557; e4.
37. + T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2012;42:1745-1755.
38. James LK, Shamji MH, Walker SM, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011;127:509-516; e1-5.
39. + Th2 inhibitory cells form in a Foxp3-independent, IL-2-dependent manner from Th2 effectors during chronic inflammation. J Immunol 2012;188:5478-5488.
40. Tanaka A, Moriyama M, Nakashima H, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum 2012;64:254-263.
41. Renand A, Archila LD, McGinty J, Wambre E, Robinson D, Hales BJ, et al. Chronic cat-allergen exposure induces a TH2 cell-dependent IgG4 response related to low-sensitization. J Allergy Clin Immunol 2015; pii: S0091-6749 (15) 01091-X. doi:10.1016/j.jaci.2015.07.031. [Epub ahead of print]
42. Moverare R, Elfman L, Bjornsson E, Stalenheim G. Changes in cytokine production in vitro during the early phase of birch-pollen immunotherapy. Scand J Immunol 2000;52:200-206.
43. + T cells and T cell anergy. Int Arch Allergy Immunol 2004;133:1-13.
44. Brooks DG, Trifilo MJ, Edelmann KH, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006;12:1301-1309.
45. Yi JS, Cox MA, Zajac AJ. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010;129:474-481.
46. Mittal SK, Roche PA. Suppression of antigen presentation by IL-10. CurrOpin Immunol 2015;34:22-27.
47. Endo Y, Hirahara K, Yagi R, et al. Pathogenic memory type Th2 cells in allergic inflammation. Trend Immunol 2014;35:69-78.
48. Wambre E, Delong EA, James EA, et al. TH2A cells as a unique TH2 cell subset in allergic individuals: steps toward a T cell biomarker for allergy. J Allergy Clin Immunol 2012;129(2 Supplemental): AB129.